drugset / Trial / NCT02999204

Effect of Vitamin D3 Supplementation on Arterial and Bone Remodeling in Chronic Kidney Disease Patients

NCT02999204

Phase 4 Completed 57 enrolled Jewish General Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

To evaluate in patients with chronic kidney disease the impact of two dosages of per os vitamin D3 supplementation (cholecalciferol) on large arterial stiffness (evaluated non invasively by pulse wave velocity and high-resolution echotracking system). We will also study arterial calcification (lateral abdominal radiography and echocardiogram), arterial remodeling (high-resolution echotracking system), endothelial function (evaluated by a non-invasive finger biosensor device), and bone remodeling (evaluated by serum biomarkers and bone mineral density).

Timeline

Start
2015-01
Primary completion
2020-09-23
Completion
2020-10-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Cholecalciferol Other / unclassified 5000 iu Oral
Subject Cholecalciferol Other / unclassified 25000 iu Oral
Subject Cholecalciferol Other / unclassified 50000 iu Oral